Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,010.00p

Buy

2,012.00p

arrow-up7.00p (+0.35%)

Prices updated at 02 May 2025, 16:49 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
FTSE All-Share
arrow-up1.09%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20232024
2,875m3,127m
1,390m1,415m
610m612m
21.2219.57
190m359m
552m727m
Sales, General and administrative544m568m
Interest expenses73m75m
Provision for income taxes89m93m
Operating expenses780m803m
Income before taxes281m455m
Net income available to common shareholders190m359m
0.861.62
Net interest income-80m-80m
Advertising and promotion--
Net investment income, net-9m-21m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.851.61
Free cash flow per share1.3091.8136
Book value/share7.77678.2648
Debt equity ratio0.4686080.282684

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20232024
Current assets2,100m2,263m
Current liabilities1,339m1,978m
Total capital3,173m2,917m
Total debt1,191m1,306m
Total equity2,198m2,310m
Total non current liabilities--
Loans975m607m
Total assets4,680m5,133m
Total liabilities--
Cash and cash equivalents205m188m
Common stock221m220m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20232024
Cash at beginning of period270m205m
Cash dividends paid-137m-175m
533m329m
Investments (gains) losses-333m-381m
205m188m
Net income--
737m564m
-204m-235m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.